Nilva Simeren Bueno de Moraes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nilva Simeren Bueno de Moraes has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Luis Filipe Nakayama
Federal University of São Paulo
2 shared publications - Amanda Frota Lacerda Morais
Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
1 shared publication - Ana Luisa Höfling-Lima
Universidade Federal de Sao Paulo, Sao Paulo, Brazil
1 shared publication - Anna Carolina B. Linhares
Universidade Federal do Paraná, Curitiba, PR, Brazil
1 shared publication - Bernardo Reichert
Médicos de Olhos S.A., Curitiba, PR, Brazil
1 shared publication - Caio Vinicius Regatieri
Retina Division, Department of Ophthalmology, Escola Paulista de Medicina, Hospital São Paulo, Universidade Federal de São Paulo, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 7 April 2026
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 12 (1)
Intracameral antibiotic prophylaxis and surgical expertise: key determinants in endophthalmitis after cataract surgery
Background: Postoperative endophthalmitis is a rare but severe complication of cataract surgery. Intracameral moxifloxacin prophylaxis has been widely adopted, but concerns remain regarding bacterial resistance and clinical outcomes. This study aimed to evaluate the impact of intracameral moxifloxacin prophylaxis on endophthalmitis incidence, microbiological patterns, antibiotic resistance, and visual outcomes in a university hospital setting, with comparison to a private hospital cohort. Methods: This retrospective cohort study analyzed 21,178 cataract surgeries performed at a university hospital (2014–2023). The incidence of endophthalmitis, microbiological profiles, resistance patterns, and visual acuity outcomes (LogMAR) were assessed. Intracameral moxifloxacin prophylaxis was introduced in 2019. A comparative analysis was conducted with 19,360 surgeries from a private hospital. Fisher’s exact test, Mann-Whitney U test, and Joinpoint regression were used for statistical analysis. Results: Endophthalmitis incidence at the university hospital was 0.109% (23/21,178 surgeries), significantly higher than the 0.021% incidence in the private hospital ( p = 0.002). Post-prophylaxis, infection rates declined from 0.219% in 2016 to 0.042% in 2023 ( p = 0.003). Staphylococcus epidermidis predominated (52.6%), and moxifloxacin resistance remained stable (pre: 45.5%; post: no increase). Conclusions: Intracameral moxifloxacin significantly reduced endophthalmitis incidence without increasing bacterial resistance. Post-prophylaxis infection rates aligned with national surveillance benchmarks (e.g., SES-SP threshold of 0.07%), reinforcing the efficacy of this preventive strategy in a public university setting. The worsening of final visual acuity post-prophylaxis underscores the need for continued clinical vigilance. Ongoing microbiological surveillance remains essential.
- 7 April 2026
- Published by Springer Nature in International Journal of Retina and Vitreous
- Vol. 12 (1)
Open AccessIntracameral antibiotic prophylaxis and surgical expertise: key determinants in endophthalmitis after cataract surgery
Background: Postoperative endophthalmitis is a rare but severe complication of cataract surgery. Intracameral moxifloxacin prophylaxis has been widely adopted, but concerns remain regarding bacterial resistance and clinical outcomes. This study aimed to evaluate the impact of intracameral moxifloxacin prophylaxis on endophthalmitis incidence, microbiological patterns, antibiotic resistance, and visual outcomes in a university hospital setting, with comparison to a private hospital cohort. Methods: This retrospective cohort study analyzed 21,178 cataract surgeries performed at a university hospital (2014–2023). The incidence of endophthalmitis, microbiological profiles, resistance patterns, and visual acuity outcomes (LogMAR) were assessed. Intracameral moxifloxacin prophylaxis was introduced in 2019. A comparative analysis was conducted with 19,360 surgeries from a private hospital. Fisher’s exact test, Mann-Whitney U test, and Joinpoint regression were used for statistical analysis. Results: Endophthalmitis incidence at the university hospital was 0.109% (23/21,178 surgeries), significantly higher than the 0.021% incidence in the private hospital ( p = 0.002). Post-prophylaxis, infection rates declined from 0.219% in 2016 to 0.042% in 2023 ( p = 0.003). Staphylococcus epidermidis predominated (52.6%), and moxifloxacin resistance remained stable (pre: 45.5%; post: no increase). Conclusions: Intracameral moxifloxacin significantly reduced endophthalmitis incidence without increasing bacterial resistance. Post-prophylaxis infection rates aligned with national surveillance benchmarks (e.g., SES-SP threshold of 0.07%), reinforcing the efficacy of this preventive strategy in a public university setting. The worsening of final visual acuity post-prophylaxis underscores the need for continued clinical vigilance. Ongoing microbiological surveillance remains essential.
- Open Access
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (3) , 1-6
Retinopathy of prematurity: Accuracy of ROPScore and WINROP algorithms in a Brazilian population
Purpose: To assess the sensitivity and specificity of the retinopathy of prematurity score (ROPScore) and weight, insulin-like growth factor-1, retinopathy of prematurity algorithm in predicting the risk of developing severe retinopathy of prematurity (prethreshold type 1) in a sample of preterm infants in Brazil. Methods: Retrospective analysis of medical records of preterm infants (n=288) with birth weight of ≤1500 g and/or gestational age of 23-32 weeks in a neonatal unit in Southern Brazil from May 2013 to December 2020 (92 months). Results: The incidence of confirmed severe retinopathy of prematurity was 6.6%. ROPScore showed a 100% sensitivity, 44.6% specificity (95% confidence interval [CI] 38.7-50.6), 11.3% positive predictive value (95% CI 6.5-16.1), and 100% negative predictive value in predicting severe retinopathy of prematurity. The weight, insulin-like growth factor-1, retinopathy of prematurity algorithm demonstrated a 78.9% sensitivity (95% CI 60.6-97.3), 51.3% specificity (95% CI 45.3-57.3), 10.3% positive predictive value (95% CI 5.3-15.2), and 97.2% negative predictive value (95% CI 94.5-99.9). Conclusion: ROPScore identified all patients at risk for severe retinopathy of prematurity. These findings support incorporating ROPScore into Brazilian guidelines to optimize retinopathy of prematurity screening and reduce unnecessary ophthalmologic examinations. Weight, insulin-like growth factor-1, retinopathy of prematurity’s suboptimal performance in this Brazilian sample highlights the need for country-specific algorithm adjustments.
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (3) , 1-6
Open AccessRetinopathy of prematurity: Accuracy of ROPScore and WINROP algorithms in a Brazilian population
Purpose: To assess the sensitivity and specificity of the retinopathy of prematurity score (ROPScore) and weight, insulin-like growth factor-1, retinopathy of prematurity algorithm in predicting the risk of developing severe retinopathy of prematurity (prethreshold type 1) in a sample of preterm infants in Brazil. Methods: Retrospective analysis of medical records of preterm infants (n=288) with birth weight of ≤1500 g and/or gestational age of 23-32 weeks in a neonatal unit in Southern Brazil from May 2013 to December 2020 (92 months). Results: The incidence of confirmed severe retinopathy of prematurity was 6.6%. ROPScore showed a 100% sensitivity, 44.6% specificity (95% confidence interval [CI] 38.7-50.6), 11.3% positive predictive value (95% CI 6.5-16.1), and 100% negative predictive value in predicting severe retinopathy of prematurity. The weight, insulin-like growth factor-1, retinopathy of prematurity algorithm demonstrated a 78.9% sensitivity (95% CI 60.6-97.3), 51.3% specificity (95% CI 45.3-57.3), 10.3% positive predictive value (95% CI 5.3-15.2), and 97.2% negative predictive value (95% CI 94.5-99.9). Conclusion: ROPScore identified all patients at risk for severe retinopathy of prematurity. These findings support incorporating ROPScore into Brazilian guidelines to optimize retinopathy of prematurity screening and reduce unnecessary ophthalmologic examinations. Weight, insulin-like growth factor-1, retinopathy of prematurity’s suboptimal performance in this Brazilian sample highlights the need for country-specific algorithm adjustments.
- Open Access
- 20 April 2022
- Published by Escola Bahiana de Medicina e Saude Publica in Journal of Evidence-Based Healthcare
- Vol. 4, e3791
Risk of bias analysis in diabetic retinopathy randomized clinical trials evaluated by RoB-1 tool from Cochrane systematic reviews
The objective of clinical trials is to answer about intervention in the real-world, for which they must be properly designed and executed by presenting the results reliably with the findings and in a clear way. OBJECTIVES: To identify the risk of bias in clinical trials about interventions for diabetic retinopathy and/or diabetic macular edema from Cochrane systematic reviews. METHODS: A sensitive search strategy was designed to search Cochrane systematic reviews of interventions in diabetic retinopathy and diabetic macular edema. The assessment of the risk of bias was captured as presented by the author. FINDINGS: We found eight SR and one meta-analysis network totaling 116 randomized clinical trials. Our sample revealed that among the domains randomization, allocation secret, masking of participants and personnel, incomplete outcomes, selective outcomes and others, the risk of bias assessed as low ranged from 30.4 to 49.1%; unclear risk between 22 to 56% and high risk from 1 to 21.7%. CONCLUSIONS: The risk of bias in diabetic retinopathy randomized clinical trials exists in high frequency and the reader must be aware of it.
- 20 April 2022
- Published by Escola Bahiana de Medicina e Saude Publica in Journal of Evidence-Based Healthcare
- Vol. 4, e3791
Open AccessRisk of bias analysis in diabetic retinopathy randomized clinical trials evaluated by RoB-1 tool from Cochrane systematic reviews
The objective of clinical trials is to answer about intervention in the real-world, for which they must be properly designed and executed by presenting the results reliably with the findings and in a clear way. OBJECTIVES: To identify the risk of bias in clinical trials about interventions for diabetic retinopathy and/or diabetic macular edema from Cochrane systematic reviews. METHODS: A sensitive search strategy was designed to search Cochrane systematic reviews of interventions in diabetic retinopathy and diabetic macular edema. The assessment of the risk of bias was captured as presented by the author. FINDINGS: We found eight SR and one meta-analysis network totaling 116 randomized clinical trials. Our sample revealed that among the domains randomization, allocation secret, masking of participants and personnel, incomplete outcomes, selective outcomes and others, the risk of bias assessed as low ranged from 30.4 to 49.1%; unclear risk between 22 to 56% and high risk from 1 to 21.7%. CONCLUSIONS: The risk of bias in diabetic retinopathy randomized clinical trials exists in high frequency and the reader must be aware of it.
- Open Access
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 85 (5) , 558-564
Evisceration and enucleation cases in the ophthalmologic emergency department of a tertiary Brazilian hospital
Purpose: To analyze the epidemiological profiles of evisceration and enucleation cases in the ophthalmologic emergency department of a Brazilian tertiary hospital. Methods: Patients treated in the ophthalmologic emergency department of Hospital Sao Paulo (Universidade Federal de Sao Paulo) during the period 2013 to 2018 were retrospectively evaluated. Urgent cases of evisceration or enucleation surgery were included, and elective cases were excluded. The following information was extracted from the patients' medical records: demographic data, immediate and associated reasons for the surgical procedure, informed visual acuity, symptom duration until ophthalmologic care, complications, distance from the residence to the tertiary hospital, and time of hospitalization. Results: In total, 61 enucleations and 121 eviscerations were included in this study. The patients had a mean age of 63.27 +/- 18.68 years. Of the patients, 99 were male (54.40%), and 83 were female (45.60%). The indications for evisceration or enucleation were corneal perforation with (44.50%) and without (23.63%) signs of infection, endophthalmitis (15.38%), ocular trauma (14.29%), neoplasia (0.55%), burn accident (1.10%), and phthisis bulbi (0.55%). The self-reported visual acuity was no light perception (87.36%) or light perception (1.10%). However, 3.30% of the patients did not cooperate with the examination, and no information on visual acuity was available for the remaining 8.24%. The mean symptom duration before ophthalmologic care was sought was 18.32 days. Two patients had sympathetic ophthalmia after evisceration. Conclusions: More eviscerations than enucleations were performed throughout the study period. The most common demographic characteristics were age >60 years and male sex. The main indications for urgent evisceration and enucleation procedures were corneal perforation with and without infection, endophthalmitis, and ocular trauma. The findings from this study could guide clinicians in performing preventive measures to avoid destructive eye procedures.
- 1 January 2021
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 85 (5) , 558-564
Open AccessEvisceration and enucleation cases in the ophthalmologic emergency department of a tertiary Brazilian hospital
Purpose: To analyze the epidemiological profiles of evisceration and enucleation cases in the ophthalmologic emergency department of a Brazilian tertiary hospital. Methods: Patients treated in the ophthalmologic emergency department of Hospital Sao Paulo (Universidade Federal de Sao Paulo) during the period 2013 to 2018 were retrospectively evaluated. Urgent cases of evisceration or enucleation surgery were included, and elective cases were excluded. The following information was extracted from the patients' medical records: demographic data, immediate and associated reasons for the surgical procedure, informed visual acuity, symptom duration until ophthalmologic care, complications, distance from the residence to the tertiary hospital, and time of hospitalization. Results: In total, 61 enucleations and 121 eviscerations were included in this study. The patients had a mean age of 63.27 +/- 18.68 years. Of the patients, 99 were male (54.40%), and 83 were female (45.60%). The indications for evisceration or enucleation were corneal perforation with (44.50%) and without (23.63%) signs of infection, endophthalmitis (15.38%), ocular trauma (14.29%), neoplasia (0.55%), burn accident (1.10%), and phthisis bulbi (0.55%). The self-reported visual acuity was no light perception (87.36%) or light perception (1.10%). However, 3.30% of the patients did not cooperate with the examination, and no information on visual acuity was available for the remaining 8.24%. The mean symptom duration before ophthalmologic care was sought was 18.32 days. Two patients had sympathetic ophthalmia after evisceration. Conclusions: More eviscerations than enucleations were performed throughout the study period. The most common demographic characteristics were age >60 years and male sex. The main indications for urgent evisceration and enucleation procedures were corneal perforation with and without infection, endophthalmitis, and ocular trauma. The findings from this study could guide clinicians in performing preventive measures to avoid destructive eye procedures.